心肾综合征(CRS)是一种心脏和肾脏功能障碍并存的复杂疾病,发病率高,治疗方案复杂。在缓解Ⅰ、Ⅱ型心肾综合征患者的充血性心衰症状方面,传统的治疗方案主要为利尿剂治疗和血液超滤,但这两种方案都存在一定的不足之处。近年来,多项研究显示腹膜透析在治疗Ⅰ、Ⅱ型心肾综合征时,能够纠正患者容量负荷过重,改善心功能,减少再住院率,也是一种有效的治疗方法。本文主要就最近国际上有关腹膜透析在Ⅰ、Ⅱ心肾综合征中的治疗效果、作用机制和可行性研究进展作一综述。 Cardiac-renal syndrome (CRS) is a complex disease in which cardiac and renal dysfunction coexist, with a high incidence and complicated treatment regimens. In terms of relieving the symptoms of congestive heart failure in patients with type I and II cardio-renal syndrome, the traditional treatment programs mainly include diuretic therapy and blood ultrafiltration, but both of these schemes have some shortcomings. In recent years, a number of studies have shown that peritoneal dialysis in the treatment of type â ... ¡, â ... ¢ type of cardio-renal syndrome, to correct patient capacity overload, improve cardiac function, reduce re-hospitalization rate, but also an effective treatment. This review summarizes the recent advances in the therapeutic effect, mechanism and feasibility of peritoneal dialysis in I and II cardiorenal syndrome.